Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow  0.00% Nasdaq Up 0.52%
Streaming
Ticker Tape: On

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
7.50 Down 0.09(1.19%) Apr 24, 4:00PM EDT
|After Hours : 7.45 Down 0.05 (0.67%) Apr 24, 5:19PM EDT
Get the big picture on all your investments.
Prev Close:7.59
Open:7.68
Bid:7.25 x 1000
Ask:7.60 x 2000
1y Target Est:14.92
Beta:1.9
Earnings Date:May 5 - May 9 (Est.)
Day's Range:7.23 - 7.79
52wk Range:5.68 - 18.18
Volume:1,514,513
Avg Vol (3m):2,374,150
Market Cap:854.25M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HALO

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Mar-14) :-0.14
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback